BIODAL 50.000/I.U 20/TAB

Benefits & Uses

Primary Benefit

Treats and prevents vitamin D deficiency, which is essential for bone health, calcium absorption, and immune function.

Health Claims

Supports bone mineralization and maintenance; promotes calcium and phosphorus absorption; contributes to normal muscle function; supports immune system function; reduces risk of vitamin D deficiency-related osteomalacia and rickets

Common Deficiency Symptoms

Fatigue, bone pain, muscle weakness, frequent infections, depression, hair loss, impaired wound healing, rickets in children, osteomalacia in adults

Target Population

Adults with confirmed vitamin D deficiency or insufficiency; individuals with limited sun exposure; elderly patients; patients with malabsorption syndromes; dark-skinned individuals; obese individuals; patients on medications that impair vitamin D metabolism

Scientific Evidence Level

Strong

Onset Timeline

Serum 25(OH)D levels begin rising within 1-2 weeks of high-dose therapy; normalization of deficiency typically achieved in 8-12 weeks; bone density improvements observed after 3-6 months of sustained adequate levels

Usage & Dosage

Suggested Use

Take 1 tablet as directed by a physician, typically once weekly or as prescribed, with a fat-containing meal

Serving Size

1 film-coated tablet

Servings Per Container

20

Best Time to Take

With meals (preferably a fat-containing meal for optimal absorption)

Recommended Daily Intake

Adults: 600 IU/day (15 mcg); therapeutic dosing for deficiency: up to 50,000 IU weekly for 3 months under supervision

Upper Tolerable Limit

4,000 IU/day (100 mcg) for adults under self-supplementation; up to 10,000 IU/day under medical supervision

Absorption Enhancers

Dietary fat (increases micellar solubilization and lymphatic absorption); magnesium (cofactor for vitamin D metabolism); bile acids

Side Effects

Possible Side Effects

At therapeutic doses under supervision: generally well-tolerated. Excessive intake may cause hypercalcemia, hypercalciuria, nausea, vomiting, constipation, polyuria, polydipsia, weakness, confusion, and nephrocalcinosis

Upper Tolerable Limit

4,000 IU/day (100 mcg) for adults under self-supplementation; up to 10,000 IU/day under medical supervision

Safety & Warnings

Contraindications

Contraindicated in hypercalcemia and/or hypercalciuria, hypervitaminosis D (vitamin D toxicity), and hypersensitivity to colecalciferol or any excipient; avoid/use only with specialist supervision in conditions predisposing to hypercalcemia such as granulomatous diseases (e.g., sarcoidosis) and severe renal impairment/nephrolithiasis.

Pregnancy Safety

Consult Doctor

Breastfeeding Safety

Consult Doctor

Children Suitability

Not recommended for self-use in children without physician supervision; dosing must be weight- and age-adjusted by a clinician

Interactions

Synergistic Nutrients

Vitamin K2 (MK-7) - directs calcium to bones and away from arteries; Calcium - works with vitamin D for bone mineralization; Magnesium - essential cofactor for vitamin D activation

Special Populations

Target Population

Adults with confirmed vitamin D deficiency or insufficiency; individuals with limited sun exposure; elderly patients; patients with malabsorption syndromes; dark-skinned individuals; obese individuals; patients on medications that impair vitamin D metabolism

Children Suitability

Not recommended for self-use in children without physician supervision; dosing must be weight- and age-adjusted by a clinician

Pregnancy Safety

Consult Doctor

Breastfeeding Safety

Consult Doctor

Storage & Patient Advice

SFDA Storage Conditions

store below 30°c

Patient Counseling

Prescription-only oral colecalciferol (vitamin D3) 50,000 IU film‑coated tablet; take exactly as prescribed (commonly once weekly for deficiency, but frequency may vary by indication and clinician plan). Take with/after a meal (preferably containing fat) to improve absorption. Do not take extra doses or combine with other high‑dose vitamin D/calcium products unless advised. Monitoring of serum 25‑OH vitamin D and calcium (± phosphate/renal function) is recommended during high‑dose therapy; seek medical advice urgently if symptoms of hypercalcemia occur (e.g., nausea/vomiting, constipation, polyuria/polydipsia, weakness, confusion). Store below 30°C.

Science & Evidence

Bioavailability Form

Cholecalciferol (Vitamin D3) - the most bioavailable form of vitamin D, approximately 87% more effective than ergocalciferol (D2) at raising and sustaining serum 25(OH)D levels

Water or Fat Soluble

Fat-soluble

Scientific Evidence Level

Strong

Onset Timeline

Serum 25(OH)D levels begin rising within 1-2 weeks of high-dose therapy; normalization of deficiency typically achieved in 8-12 weeks; bone density improvements observed after 3-6 months of sustained adequate levels

Food Sources

Fatty fish (salmon, mackerel, sardines), cod liver oil, egg yolks, beef liver, UV-exposed mushrooms, fortified milk and dairy products, fortified cereals

Product Information

Supplement Type

Vitamin

Allergen Info

No common allergens declared; product is a film-coated tablet - specific excipients not publicly disclosed; patients with known tablet coating sensitivities should consult the manufacturer

Certification

SFDA registered (Registration No. 1811211339); GMP manufactured by Hayat Pharmaceutical Industries, Jordan

Suitable for Vegans

No

Vitamin D Form

D3

Calcium Included

No

Vitamin K Included

No